Delivery Order SPE2DB22D1202-SPE2DB24FUQA1
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $3.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,412.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceuticals. The contract has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,440.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a completion date of April 11, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The $1,625.00 order is for the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a range of pharmaceuticals, medical supplies, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.24 firm fixed price delivery order is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there are no subcontractors mentioned. This award...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $3,937.95 to provide XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with a performance period through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen Drug Corp to...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,077.48 and a period of performance through July 29, 2024. This contract is not set aside for a specific business type. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded this delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed-price delivery order worth $1,539.05 to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. This order is for the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML and has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, is also the prime contractor on a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The $2,713.71 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceutical products and medical supplies to U.S. government...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency, with a ceiling value of $1,248.70. The contract has a firm fixed-price pricing type and an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and the parent...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,252.44 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUQA1Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The potential value of this contract is $3,817.38, with a period of performance through February 9, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a wide range of pharmaceutical and medical supplies to U.S. government agencies, including the Department of Defense, through various indefinite delivery contracts. This specific award is not associated with any set-aside designation.
Generated 5/9/24, 10:46 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 2/8/24 |